Baxter International Inc vs Becton Dickinson & Co

Baxter International Inc (BAX) is overvalued and Becton Dickinson & Co (BDX) is fairly valued.

Against our estimates of intrinsic value, BDX trades at the wider discount: a margin of safety of +4%, against -182% for BAX.

Values as of the 22 Sept 2026 close.

Baxter International Inc (BAX)

Discounting its cash flows at 7.3% values the shares at $8.41; the price of $23.68 is 182% above that value, and 81% of that value comes from beyond year five.

Leak Score 0/100 on 2 of 12 signals

Becton Dickinson & Co (BDX)

Discounting its cash flows at 7.0% (average of 3 methods) values the shares at $190.08; the price of $183.00 is 4% below that value, and 83% of that value comes from beyond year five.

Leak Score 34/100 on 9 of 12 signals

MetricBAXBDX
VerdictOvervaluedFairly valued
Price$23.68$183.00
Intrinsic value$8.41$190.08
Margin of safety-182%+4%
Leak Score0/100 (2/12)34/100 (9/12)
Market cap$12.2B$49.8B
Revenue growth, 5 years-0.8%6.3%
Operating margin5.6%14.5%
Net margin-8.6%4.5%
Return on equity-14.3%5.2%
Debt to equity1.430.69
P/E55.2x
Forward P/E11.6x13.8x
P/B2.0x2.0x
Dividend yield0.2%2.2%

All stocks in Medical Instruments & Supplies